- Home
- BY vs COLL Comparison
BY vs COLL Comparison
Compare BY & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BY
- COLL
- Stock Information
- Founded
- BY 1914
- COLL 2002
- Country
- BY United States
- COLL United States
- Employees
- BY N/A
- COLL N/A
- Industry
- BY Major Banks
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- BY Finance
- COLL Health Care
- Exchange
- BY Nasdaq
- COLL Nasdaq
- Market Cap
- BY 1.1B
- COLL 910.2M
- IPO Year
- BY 2017
- COLL 2015
- Fundamental
- Price
- BY $24.18
- COLL $27.01
- Analyst Decision
- BY Hold
- COLL Strong Buy
- Analyst Count
- BY 3
- COLL 5
- Target Price
- BY $33.67
- COLL $43.60
- AVG Volume (30 Days)
- BY 204.4K
- COLL 500.0K
- Earning Date
- BY 04-24-2025
- COLL 05-08-2025
- Dividend Yield
- BY 1.65%
- COLL N/A
- EPS Growth
- BY 3.00
- COLL 43.56
- EPS
- BY 2.75
- COLL 1.86
- Revenue
- BY $379,856,000.00
- COLL $631,449,000.00
- Revenue This Year
- BY $14.42
- COLL $19.96
- Revenue Next Year
- BY $5.03
- COLL $3.93
- P/E Ratio
- BY $8.79
- COLL $14.55
- Revenue Growth
- BY 7.52
- COLL 11.41
- 52 Week Low
- BY $19.82
- COLL $23.23
- 52 Week High
- BY $32.89
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- BY 39.74
- COLL 43.16
- Support Level
- BY $22.63
- COLL $23.23
- Resistance Level
- BY $24.10
- COLL $27.57
- Average True Range (ATR)
- BY 1.05
- COLL 1.45
- MACD
- BY -0.02
- COLL -0.08
- Stochastic Oscillator
- BY 36.73
- COLL 51.82
About BY Byline Bancorp Inc.
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.